Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO)

Shu, X; Prochazka, M; Lannering, B; Schüz, J; Röösli, M; Tynes, T; Kuehni, C E; Andersen, T V; Infanger, D; Schmidt, L S; Poulsen, A H; Klaeboe, L; Eggen, T; Feychting, M (2014). Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO). Annals of oncology, 25(4), pp. 902-908. Oxford University Press 10.1093/annonc/mdu048

[img] Text
Shu AnnOncol 2014.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (115kB) | Request a copy
[img]
Preview
Text
mdu048.pdf - Other
Available under License Publisher holds Copyright.

Download (114kB) | Preview

BACKGROUND A number of epidemiological studies indicate an inverse association between atopy and brain tumors in adults, particularly gliomas. We investigated the association between atopic disorders and intracranial brain tumors in children and adolescents, using international collaborative CEFALO data. PATIENTS AND METHODS CEFALO is a population-based case-control study conducted in Denmark, Norway, Sweden, and Switzerland, including all children and adolescents in the age range 7-19 years diagnosed with a primary brain tumor between 2004 and 2008. Two controls per case were randomly selected from population registers matched on age, sex, and geographic region. Information about atopic conditions and potential confounders was collected through personal interviews. RESULTS In total, 352 cases (83%) and 646 controls (71%) participated in the study. For all brain tumors combined, there was no association between ever having had an atopic disorder and brain tumor risk [odds ratio 1.03; 95% confidence interval (CI) 0.70-1.34]. The OR was 0.76 (95% CI 0.53-1.11) for a current atopic condition (in the year before diagnosis) and 1.22 (95% CI 0.86-1.74) for an atopic condition in the past. Similar results were observed for glioma. CONCLUSIONS There was no association between atopic conditions and risk of all brain tumors combined or of glioma in particular. Stratification on current or past atopic conditions suggested the possibility of reverse causality, but may also the result of random variation because of small numbers in subgroups. In addition, an ongoing tumor treatment may affect the manifestation of atopic conditions, which could possibly affect recall when reporting about a history of atopic diseases. Only a few studies on atopic conditions and pediatric brain tumors are currently available, and the evidence is conflicting.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Kühni, Claudia

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

06 Oct 2014 14:59

Last Modified:

27 Oct 2019 11:25

Publisher DOI:

10.1093/annonc/mdu048

PubMed ID:

24608192

Uncontrolled Keywords:

allergy, brain tumors, case–control study, childhood, glioma

BORIS DOI:

10.7892/boris.48160

URI:

https://boris.unibe.ch/id/eprint/48160

Actions (login required)

Edit item Edit item
Provide Feedback